Spectral Medical (TSX:EDT) COGS-to-Revenue : 0.82 (As of Jun. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Spectral Medical COGS-to-Revenue?

Spectral Medical's Cost of Goods Sold for the three months ended in Jun. 2024 was C$0.39 Mil. Its Revenue for the three months ended in Jun. 2024 was C$0.47 Mil.

Spectral Medical's COGS to Revenue for the three months ended in Jun. 2024 was 0.82.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Spectral Medical's Gross Margin % for the three months ended in Jun. 2024 was 17.62%.

Spectral Medical COGS-to-Revenue Historical Data

The historical data trend for Spectral Medical's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spectral Medical COGS-to-Revenue Chart

Spectral Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.23

0.30

0.40

0.41

0.59

Spectral Medical Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
COGS-to-Revenue	Get a 7-Day Free Trial															0.92	0.77	0.59	0.42	0.82

Spectral Medical COGS-to-Revenue Calculation

Spectral Medical's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.936	/	1.598
	=	0.59

Spectral Medical's COGS to Revenue for the quarter that ended in Jun. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.388	/	0.471
	=	0.82

Spectral Medical (TSX:EDT) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Spectral Medical's Gross Margin % for the three months ended in Jun. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.388 / 0.471
	=	17.62 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Spectral Medical COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Spectral Medical's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Spectral Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Spectral Medical Inc (TSX:EDT) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

EDTXF:USA SD4:Germany

Address

135 - 2 The West Mall, Finance, Toronto, ON, CAN, M9C 1C2

Website

https://www.spectraldx.com

Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. The company has one reporting segment Spectral Medical Inc. The Dialco Medical Inc. operations were considered discontinued by the company.

Executives

Anthony Phillip Bihl	Director
William Charles Stevens	Director